No Detail Found!

Histological alterations of cervical cancer following Zanthoxylum acanthopodium DC therapy in relation to E7, pRb, EGFR and p16 Expression expression

Author(s)
Rostime Hermayerni Simanullang, Department of Nursing, Faculty of Nursing, Universitas Murni Teguh, Medan, Indonesia
Jekson Martiar Siahaan Department of Molecular Biology, Faculty of Medicine, Universitas Methodist Indonesia, Medan, Indonesia
Putri Cahaya Situmorang Department of Biology, Faclty of Mathematics and Natural Sciences, Universitas Sumatera Utara, Medan, Indonesia
Abstract
Background and Objective: Cervical cancer is the second most common cancer in Indonesia, where traditional herbal treatments like Zanthoxylum acanthopodjum (andaliman) are culturally used. Investigating protein biomarkers such as E7, pRb, EGFRand p16 can help assess the efficacy of these treatments. Materialasnd Methods: There were 5 groups in this study: 2 control groups (C- and C+) and 3 treatment groups (each receiving one of three doses). Oral administration of andaliman was performedfor 30 days in cancer model rats, afterwhich the cervix was dissected, cervical tissue was taken and immunohistochemistry repair was performed. Statistical analysis was performed using the Kruskal-Wallis test with a p<0.05. Results: As Zanthoxylum acanthopodium DC dose rose, cervical tissue E7, EGFR and p16 expression decreased. However, greater doses of this plant increased cervical tissue pRb protein. Cervical cancer histology exhibited increased nuclear size, irregular cellular structure, atypical cell shape, higher nuclear-cytoplasmic ratio and various nuclear shape variants. This herb induced tissue to show well-organized non-hyperchromatic cells that resembled normal clusters. Conclusion: Zanthoxylum acanthopodiumDCimproved cervical tissue and balanced cervical cancer biomarker proteins such E7, EGFR, pRBand p16.
Publication Details
Page(s) 602-612
Published Journal: Pakistan Journal of Biological Sciences, Volume: 27, Issue: 12, Year: 2024

Request the full text from PASTIC

Keywords
Cervical Cancer, epidermal growth factor receptor protein (EGFR), Human Papillomavirus (HPV), Zanthoxylum acanthopodiumDC, retinoblastoma protein (pRB)
References
Mitra S,Lami M.S.,Ghosh A.,Das R.,T.E. Tallei etal R. .2022 .. , : .
. .Hormonal therapy for gynecological cancers: How far has science progressed toward clinical applications? Cancers. , 14 : .
Burmeister N.,Mbatani T.,Adams J.,Moodley S.,Prince S. .2022 .Cervical cancer therapies: Current challenges and future perspectives. Tumour Virus Res,, 200238 : .
Park M.,Kim S.,Lee W.,Jung B.,Kim B. .2021 .. , : .
. .Therapeutic potential of natural products in treatment of cervical cancer: A review. Nutrients, 13 : .
. .. , : .
Pal A.,Kundu R. .2020 .Human papillomavirus E6 and E7: The cervical cancer hallmarks and targets for therapy.. , : .
Front. Microbiol, .2019 .. , 03116 : .
Hickman E.S. M.C.,Moroni K.,Helin K. .2002 .The roleof p53 and pRBin apoptosis and cancer. Curr. Opin. Genet, 12 : 60-66.
Wee P.,Wang Z. .2017 .Epidermal growth factor receptor cell proliferation signaling pathways. Cancers, 9 : .
. .. , : .
Hatanpaa S.,Burma D.,Zhao A.A.,Habib A.A. .2010 .. , : .
Neoplasia . .. , 12 : 675-684.
Yeo-Teh N.,SL Y.,Ito S.,Jha S. .2018 .High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis. Int. J. Mol. Sci, 19 : .
Ganetzky R,Bagchi A.,Zollo O.,Conlin L. .2015 .EGFR mutations cause a lethal syndrome of epithelial dysfunction with progeroid features. Mol. Genet. Genomic Med, 3 : 452-458.
Kamran S.,Sinniah A. .2022 .Therapeutic potential of certain terpenoids as anticancer agents: A scoping review. Cancers, 14 : .
Zhou ,HZ S.G.,Xu F.J.,Li L.C.,Gao L.C. .2022 .Therapeutic effects of natural products on cervical cancer: Based on inflammatory pathways. Front. Pharmacol,, 899208 : .
Qian Z.,Wei W.,Yang J.,Huang Y.,Yang J.,Wang J. .2022 .The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front. Oncol, 985363 : .
Carneiro F.P,,M. de Vasconcelos Carneiro T.,MML. de Castro and L.M. de Souza T. .2020 .P16 asamarkerof carcinoma in effaund speriitonoeal nwasshing. BMC Cancer, 20 : 512885.
Vazquez-Villasefior ,C.J. Garwood P.R.,Heath J.E.,Simpson P.G.,Ince S.B.,Wharton S.B. .2020 .Expression of p16 and p21 in the frontal association cortex of ALS/MND brains suggests neuronal cell cycle dysregulation and astrocyte senescence in early stages of the disease. Neuropathol. Appl, 46 : 171-185.
Kopustinskiene D.M. V.,Jakstas A.,Savickas J.,Bernatoniene J. .2020 .Flavonoids as anticancer agents. Nutrients, 12 : .
Okagu I.U,Ndefo J.C.,Aham E.C.,Udenigwe C.C. .2021 .Zanthoxylum species: A review of traditional uses, phytochemistry and pharmacology in relation to cancer, infectious diseases and sickle cell anemia. Front. Pharmacol., 713090 : .
0

Citations

0

Downloads

73

Views